| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |